As the impact of COVID-19 intensifies globally, governments and healthcare systems come under extraordinary pressure. And healthcare professionals are holding the front line to save lives.
At Qmed our mantra is “enabling better health” and we are supporting companies worldwide in finding and establishing the right regulatory and clinical pathways for existing and new innovative medical devices and are managing numerous important clinical investigations worldwide. During this time we are committed to keeping our employees and partners safe, help flattening the curve of COVID-19 infection spread following the guidelines and recommendations from the authorities in the individual countries.
We are here….!
We focus on maintaining a steady delivery and supporting our customers in any way we can. We have implemented a plan to ensure the health and safety of our employees, their families and the clients we serve whilst maintaining an uninterrupted service.
Qmed has asked all employees to work remotely and have established a smooth and efficient system to allow our team to work from home “together apart” where all activities and communications will continue as before. We are committed to providing the best level of response to our clients during the current difficult environment.
To better understand the impact of the COVID 19 situation on client projects and clinical studies in order to mitigate risk we are continuously in close contact with our network and are gathering information from EU Member State authorities, Notified Bodies, the EU Commission, Ethics Committees and hospitals to better understand the situation.
We will continue to monitor the spread of COVID-19 over the coming weeksand months, and will try to provide guidance on a timely basis. We will make this information available as soon as possible either through our homepage or our community at the social media.
Please feel free to contact any of us in case of any questions or concerns in regards to the ongoing situation.
Our vision “Enable better help” remains unchanged. We continue to focus on maintaining our client’s interest. The COVID-19 virus challenge reminds us of the importance of bringing new innovative products to the market, as fast as we can.
Chief Executive Officer